arrow
L

Lieveke Ameye

universite libre de bruxelles
H指数:52
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study

内分泌治疗联合CDK4/6抑制剂后进展的ER阳性/HER2阴性晚期乳腺癌中依维莫司的有效性:EVERGREEN研究

2026-07-100
PRE
Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer

癌症患者对mRNA抗SARS-CoV-2疫苗接种的长期免疫反应

2026-05-200
OAAI
Personalized ctDNA detection and genomic profiling in the NeoRHEA Study

个性化循环肿瘤DNA检测和基因组分析在NeoRHEA研究中

2025-12-050
OAAI
Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study

Palbociclib和内分泌疗法减弱早期乳腺癌的适应性抗肿瘤免疫:NeoRHEA 2期研究

2025-11-260
OAAI
Characteristics, Treatment Patterns and Clinical Outcomes of Women with Maghreb Origin and Diagnosis of Breast Cancer: A Single-Center, Retrospective Cohort Study

特征、治疗模式及临床结局:具有马格里伯血统并被诊断为乳腺癌的女性——一项单中心、回顾性队列研究

2025-06-270
PRE
Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial

avelumab为基础的新辅助疗法在肌肉浸润性膀胱癌患者中的应用(AURA Oncodistinct-004):一项多中心二期临床试验

2025-05-240
OA
Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial

在APHINITY试验中,他汀类药物使用与早期HER2阳性乳腺癌患者生存结局的关联

2025-04-280
OA
Subtype-specific prognostic value of lobular histology in patients with early-stage breast cancer: A nationwide population-based study

小叶组织学在早期乳腺癌患者中的亚型特异性预后价值:一项全国性基于人群的研究

2024-09-010
PRE
EVERolimus effectiveness after proGREssion on CDK4/6 inhibitors for ENdocrine receptor-positive/HER2-negative, advanced breast cancer: EVERGREEN quasi-experimental study

依维莫司在CDK4/6抑制剂进展后的内分泌受体阳性/HER2阴性晚期乳腺癌中的疗效:EVERGREEN准实验研究

2024-09-010
PRE
Progression-free survival assessment by local investigators versus blinded independent central review in randomized clinical trials in metastatic breast cancer: A systematic review and meta-analysis

在转移性乳腺癌的随机临床试验中,本地研究人员的无进展生存评估与盲法独立中心审查的比较: 系统评价和荟萃分析

2024-01-011
PRE
Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
2023-12-2116
OA